Evidence map›Paper›PMID 40248600›Full record

ArticleFrontiers in psychiatry2025

Oxytocin does not impact forced-choice recognition memory in an experimental trauma film paradigm with healthy women.

Tolou Maslahati, Franziska Glogau, Milagros Galve Gómez, Katharina Buchholz, Lisa Dormann, Katja Wingenfeld, Christian Otte, Katharina Schultebraucks, Stefan Roepke

Abstract read
In one paragraph

Article in Frontiers in psychiatry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Tolou MaslahatiDepartment of Psychiatry and Psychotherapy, Campus Benjamin Franklin (CBF), Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.
Franziska GlogauDepartment of Psychiatry and Psychotherapy, Campus Benjamin Franklin (CBF), Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.
Milagros Galve GómezDepartment of Psychiatry and Psychotherapy, Campus Benjamin Franklin (CBF), Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.
Katharina BuchholzDepartment of Psychiatry and Psychotherapy, Campus Benjamin Franklin (CBF), Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.
Lisa DormannDepartment of Psychiatry and Psychotherapy, Campus Benjamin Franklin (CBF), Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.
Katja WingenfeldDepartment of Psychiatry and Psychotherapy, Campus Benjamin Franklin (CBF), Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.
Christian OtteDepartment of Psychiatry and Psychotherapy, Campus Benjamin Franklin (CBF), Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.
Katharina SchultebraucksDepartment of Psychiatry and Psychotherapy, Campus Benjamin Franklin (CBF), Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.
Stefan RoepkeDepartment of Psychiatry and Psychotherapy, Campus Benjamin Franklin (CBF), Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Traumatic experiences are thought to alter memory acquisition and consolidation. Cognitive models of PTSD suggest that voluntary and involuntary memories after trauma can be independently addressed through interventions. The administration of oxytocin before exposure to a trauma film led to more intrusive (involuntary) memories than placebo. The effect of oxytocin on voluntary memory of the traumatic film, however, remains unclear. The current study aimed to assess whether intranasal oxytocin administration facilitates forced-choice recognition memory after a trauma film paradigm. Material & methods: We performed a pooled analysis of two randomized, double-blind, placebo-controlled studies (N = 437) to assess the impact of intranasal oxytocin administration on declarative memory. Participants received 24 I.U. of oxytocin, either 40 minutes before a trauma film paradigm or immediately afterward. We applied a forced-choice recognition task seven days after the trauma film paradigm. The task comprised pre-, peri, and post-trauma film scene details. Results: The administration of oxytocin did not affect recognition performance for any film scene ( Discussion: Although the exogenous oxytocin administration before a trauma film has been shown to influence the acquisition of intrusive memories, it does not seem to affect the recognition memory of trauma film details. That aligns with cognitive models of PTSD, suggesting that voluntary and involuntary memory after trauma can be independently addressed through experimental interventions.

Indexed as

forced choice memoryoxytocinPTSDrecognition memorytraumatrauma film paradigm

Identifiers

PMID40248600
PMCPMC12003341

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.